{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:51:57Z","timestamp":1789991517619,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31270980"],"award-info":[{"award-number":["31270980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.09.058","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T23:50:37Z","timestamp":1507765837000},"page":"1684-1692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pretreatment of Pam3CSK4 attenuates inflammatory responses caused by systemic infection of methicillin-resistant Staphylococcus aureus in mice"],"prefix":"10.1016","volume":"95","author":[{"given":"Zhaoxia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayu","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.09.058_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4161\/viru.25436","article-title":"Host innate immune responses to sepsis","volume":"5","author":"Wiersinga","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.biopha.2017.09.058_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia\u2014a systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.biopha.2017.09.058_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/CMR.18.3.521-540.2005","article-title":"Recognition of Staphylococcus aureus by the innate immune system","volume":"18","author":"Fournier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2017.09.058_bib0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.5301\/ijao.5000030","article-title":"Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus","volume":"34","author":"Pietrocola","year":"2011","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.biopha.2017.09.058_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0030","first-page":"123","article-title":"Host innate immune responses to microbial pathogens","volume":"11","author":"Delaloye","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/CMR.16.3.379-414.2003","article-title":"Receptors mediators, and mechanisms involved in bacterial sepsis and septic shock","volume":"16","author":"Van Amersfoort","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2017.09.058_bib0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nri1630","article-title":"Negative regulation of toll-like receptor-mediated immune responses","volume":"5","author":"Liew","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0045","doi-asserted-by":"crossref","DOI":"10.4081\/idr.2010.e9","article-title":"IRAK-M regulation and function in host defense and immune homeostasis","volume":"2","author":"Hubbard","year":"2010","journal-title":"Infect Dis. Rep."},{"key":"10.1016\/j.biopha.2017.09.058_bib0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","article-title":"IRAK-M is a negative regulator of Toll-like receptor signaling","volume":"110","author":"Kobayashi","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.09.058_bib0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/emboj.2013.2","article-title":"IRAK-M mediates toll-like receptor\/IL-1R-induced NFkappaB activation and cytokine production","volume":"32","author":"Zhou","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2017.09.058_bib0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.micinf.2011.08.018","article-title":"Tollip: a multitasking protein in innate immunity and protein trafficking","volume":"14","author":"Capelluto","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.biopha.2017.09.058_bib0065","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.2174\/092986706778201675","article-title":"Toll-like receptor (TLR) response tolerance: a key physiological damage limitation effect and an important potential opportunity for therapy","volume":"13","author":"Broad","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2017.09.058_bib0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SHK.0b013e318150776f","article-title":"Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus","volume":"29","author":"Murphey","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2017.09.058_bib0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/IAI.69.1.463-471.2001","article-title":"Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response","volume":"69","author":"Lehner","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2017.09.058_bib0080","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1128\/IAI.68.6.3748-3753.2000","article-title":"Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection","volume":"68","author":"Rayhane","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2017.09.058_bib0085","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/092986708783503249","article-title":"Self-adjuvanting lipopeptide vaccines","volume":"15","author":"Moyle","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2017.09.058_bib0090","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/intimm\/dxh282","article-title":"Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation","volume":"17","author":"Feterowski","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0095","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1053\/j.gastro.2007.02.056","article-title":"Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function","volume":"132","author":"Cario","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.09.058_bib0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1086\/649589","article-title":"Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis","volume":"201","author":"Kumar","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2017.09.058_bib0105","first-page":"e149233","article-title":"Control of methicillin-resistant Staphylococcus aureus pneumonia utilizing TLR2 agonist Pam3CSK4","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.09.058_bib0110","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2017.09.058_bib0115","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.4049\/jimmunol.165.10.5392","article-title":"Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection","volume":"165","author":"Takeuchi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0120","doi-asserted-by":"crossref","first-page":"13766","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors","volume":"97","author":"Ozinsky","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.09.058_bib0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.09.058_bib0130","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.082100399","article-title":"IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase","volume":"99","author":"Li","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.09.058_bib0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2014.00553","article-title":"IL-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance","volume":"5","author":"Jain","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0140","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.173.4.2736","article-title":"Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1","volume":"173","author":"Siedlar","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","article-title":"Endotoxin tolerance: new mechanisms, molecules and clinical significance","volume":"30","author":"Biswas","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0150","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/j.1365-2222.2008.03056.x","article-title":"Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route","volume":"38","author":"Lombardi","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.biopha.2017.09.058_bib0155","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.1101764","article-title":"MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action","volume":"188","author":"Caproni","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0160","doi-asserted-by":"crossref","first-page":"H984","DOI":"10.1152\/ajpheart.01109.2009","article-title":"TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism","volume":"298","author":"Ha","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0165","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/icb.2011.37","article-title":"Bacterial lipoprotein-induced tolerance is reversed by overexpression of IRAK-1","volume":"90","author":"Li","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cellsig.2008.10.009","article-title":"Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages","volume":"21","author":"De Nardo","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2017.09.058_bib0175","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1189\/jlb.0905505","article-title":"Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation","volume":"79","author":"Li","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0180","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1074\/jbc.M308620200","article-title":"Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages","volume":"279","author":"Nakayama","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.09.058_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jss.2007.12.759","article-title":"Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells","volume":"150","author":"Liu","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2017.09.058_bib0190","doi-asserted-by":"crossref","first-page":"e87528","DOI":"10.1371\/journal.pone.0087528","article-title":"A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cells","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.09.058_bib0195","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1189\/jlb.0611273","article-title":"Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20","volume":"90","author":"Xiong","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2017.09.058_bib0200","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/IAI.00149-12","article-title":"Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus","volume":"80","author":"Kochan","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2017.09.058_bib0205","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/IAI.00022-11","article-title":"The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection","volume":"79","author":"Romero","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2017.09.058_bib0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4049\/jimmunol.170.1.14","article-title":"Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock","volume":"170","author":"Wang","year":"2003","journal-title":"J. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217331074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217331074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:46:38Z","timestamp":1771400798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217331074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":42,"alternative-id":["S0753332217331074"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.058","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment of Pam3CSK4 attenuates inflammatory responses caused by systemic infection of methicillin-resistant Staphylococcus aureus in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.09.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}